Board Meetings for ALKEM
Detailed list of historic and upcoming board meetings.
| Symbol | Company | Meeting Date | Purpose | Description | Links |
|---|---|---|---|---|---|
| ALKEM | Alkem Laboratories Limited | 30 May 2018 | Financial Results/Dividend | Notice is hereby given to the Stock Exchanges under Regulation 29 read with Regulation 33 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, 30th May, 2018, inter alia, (i) to consider and approve the Standalone and Consolidated Audited Financial Results of the Company for the quarter and financial year ended 31st March, 2018; and(ii) to consider and recommend Final Dividend, if any, for the Financial Year ended 31st March, 2018.Kindly take note of the same. | |
| ALKEM | Alkem Laboratories Limited | 09 Feb 2018 | Results/Dividend | , inter alia: (i) to consider and approve the Standalone and Consolidated Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2017; and (ii) to consider and approve Interim Dividend for the Financial Year 2017-2018. | |
| ALKEM | Alkem Laboratories Limited | 10 Nov 2017 | Results | Inter alia, to consider and approve the Standalone and Consolidated Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2017. | |
| ALKEM | Alkem Laboratories Limited | 11 Aug 2017 | Results | inter alia, to consider and approve the Standalone and Consolidated Unaudited Financial Results of the Company for the quarter ended June 30, 2017. | |
| ALKEM | Alkem Laboratories Limited | 26 May 2017 | Results/Dividend | inter alia, (i) to consider and approve the Standalone and Consolidated Audited Financial Results of the Company for the quarter and financial year ended March 31, 2017; and (ii) to consider and recommend Final Dividend, if any, for the Financial Year ended March 31, 2017. | |
| ALKEM | Alkem Laboratories Limited | 10 Feb 2017 | Results | inter alia, to consider and approve the Standalone and Consolidated Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2016. | |
| ALKEM | Alkem Laboratories Limited | 11 Nov 2016 | Results/Dividend | inter alia: (i) to consider and approve the Standalone and Consolidated Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2016; and (ii) to consider and approve Interim Dividend for the Financial Year 2016-2017. | |
| ALKEM | Alkem Laboratories Limited | 12 Aug 2016 | Results | inter alia, to consider and approve the Standalone and Consolidated Unaudited Financial Results of the Company for the quarter ended 30th June, 2016. | |
| ALKEM | Alkem Laboratories Limited | 27 May 2016 | Results | To consider and approve the Standalone and Consolidated Audited Financial Results of the Company for the quarter and financial year ended March 31, 2016. | |
| ALKEM | Alkem Laboratories Limited | 09 Mar 2016 | Dividend | Inter alia to consider and approve second interim dividend for the Financial Year 2015-16. | |
| ALKEM | Alkem Laboratories Limited | 12 Feb 2016 | Results | Inter alia , to consider and approve the Standalone and Consolidated Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2015. |
Showing page 4 of 4 (56 total items)